Cancer Embolization Device Estimated to Witness Robust Growth Owing to Increasing Cancer Prevalence and New Product Launches
by The cancer embolization device market is estimated to be valued at US$ 1,433.6 million in 2022 and is expected to exhibit a CAGR of 8.1% …